Skip to end of metadata
Go to start of metadata

You are viewing an old version of this page. View the current version.

Compare with Current View Page History

« Previous Version 22 Current »

Business' relevance

Whereas CQ1 starts with an active moiety, and identifies all substances having that common active moiety, CQ2 starts with a substance and identifies the active moiety for the substance. A substance is defined as a matter of defined composition that has discrete existence, whose origin may be biological, mineral or chemical. A moiety is an entity within a substance that has a complete and continuous molecular structure. The strength of a pharmaceutical product is often based on what is referred to as the active moiety of the molecule, responsible for the physiological or pharmacological action of the drug substance. Linking a substance and it's active moiety not only gives immediate clarity on how the substance potentially exerts it's pharmacological activity, but also (due to the way the ontology is modeled) gives an overview of how active moieties can be differently defined under different contexts.

Diagram for Query Pattern


Diagram 1: Query pattern diagram for SPARQL Query

Test Data

Amlodipine example: https://github.com/edmcouncil/idmp/blob/master/EXT/Examples/AmlodipineExample.rdf

Terlipressin Example: https://github.com/edmcouncil/idmp/blob/master/EXT/Examples/TerlipressinExample.rdf

SPARQL Query

https://github.com/edmcouncil/idmp/blob/master/etc/CQ/Example/uc1_cq2.sparql


Expected Query Result for Amlodipine Example Data

Expected Query Result for Terlipressin Example Data


  • No labels